𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study

✍ Scribed by José M. Ponseti; Jamal Azem; José M. Fort; Agustín Codina; J. Bruno Montoro; Manuel Armengol


Book ID
116368823
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
70 KB
Volume
107
Category
Article
ISSN
0303-8467

No coin nor oath required. For personal study only.